Sep 28, 2018
ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX
Sep 05, 2018
Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy
Aug 01, 2018
Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy
Jul 30, 2018
ITUS Corporation Releases Results for Cchek(TM) Breast Cancer Study
Jul 06, 2018
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
Jun 29, 2018
ITUS to Ring the NASDAQ Closing Bell on July 5th
Jun 26, 2018
ITUS Accelerates Schedule for its CAR T Therapy and Provides Update
Jun 13, 2018
ITUS Corporation Announces First Commercial Focus for Cchek(TM) will be Prostate Cancer
Apr 02, 2018
ITUS Presentation to Special Meeting of Stockholders
Mar 27, 2018
ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study
Mar 16, 2018
ITUS to Present Data from Early Cancer Detection Study Utilizing Artificial Intelligence at the American Association of Immunologists (AAI) Meeting
Mar 12, 2018
ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting
Mar 09, 2018
ITUS Corporation to Present at the 2018 Inaugural China Healthcare Investment & Partnering Symposium (CHIPS)
Feb 07, 2018
ITUS will Present Artificial Intelligence Powered Early Cancer Detection Technology at the Keystone Symposia Conference - Cancer Immunotherapy: Combinations
Jan 29, 2018
ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium
Jan 22, 2018
ITUS Will Present Early Cancer Detection Data at ASCO-SITC Symposium on January 26
Dec 12, 2017
ITUS Corporation Terminates At-The-Market Offering
Dec 06, 2017
ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium
Nov 28, 2017
ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent
Nov 22, 2017
ITUS Conference Call Recording Available on Company Website